Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

July 26, 2024 01:00 ET | Source: Ackermans & van Haaren Ackermans & van Haaren

Dear shareholder,

Dear Madam, Dear Sir,

please find attached our press release.

Best regards

Ackermans & van Haaren

Attachment

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics (press release 26 July 2024)...